Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Other Working Capital Changes: 2021-2025

Historic Other Working Capital Changes for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $507,000.

  • Kiniksa Pharmaceuticals International's Other Working Capital Changes fell 92.75% to $507,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year increase of 105.41%. This contributed to the annual value of $19.6 million for FY2024, which is 176.64% up from last year.
  • According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Other Working Capital Changes is $507,000, which was down 92.62% from $6.9 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Other Working Capital Changes high stood at $14.3 million for Q3 2022, and its period low was -$14.3 million during Q4 2022.
  • Moreover, its 3-year median value for Other Working Capital Changes was $5.3 million (2025), whereas its average is $3.6 million.
  • Data for Kiniksa Pharmaceuticals International's Other Working Capital Changes shows a peak YoY increase of 2,950.36% (in 2022) and a maximum YoY decrease of 1,051.49% (in 2022) over the last 5 years.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Other Working Capital Changes (Quarterly) stood at -$1.2 million in 2021, then crashed by 1,051.49% to -$14.3 million in 2022, then soared by 38.10% to -$8.8 million in 2023, then surged by 134.38% to $3.0 million in 2024, then slumped by 92.75% to $507,000 in 2025.
  • Its Other Working Capital Changes was $507,000 in Q3 2025, compared to $6.9 million in Q2 2025 and $5.3 million in Q1 2025.